Correlation Between Bristol Myers and Antofagasta PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Antofagasta PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Antofagasta PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Antofagasta PLC, you can compare the effects of market volatilities on Bristol Myers and Antofagasta PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Antofagasta PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Antofagasta PLC.

Diversification Opportunities for Bristol Myers and Antofagasta PLC

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol and Antofagasta is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Antofagasta PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antofagasta PLC and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Antofagasta PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antofagasta PLC has no effect on the direction of Bristol Myers i.e., Bristol Myers and Antofagasta PLC go up and down completely randomly.

Pair Corralation between Bristol Myers and Antofagasta PLC

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.7 times more return on investment than Antofagasta PLC. However, Bristol Myers Squibb is 1.43 times less risky than Antofagasta PLC. It trades about 0.13 of its potential returns per unit of risk. Antofagasta PLC is currently generating about -0.11 per unit of risk. If you would invest  4,940  in Bristol Myers Squibb on September 25, 2024 and sell it today you would earn a total of  793.00  from holding Bristol Myers Squibb or generate 16.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Antofagasta PLC

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.
Antofagasta PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Antofagasta PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Bristol Myers and Antofagasta PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Antofagasta PLC

The main advantage of trading using opposite Bristol Myers and Antofagasta PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Antofagasta PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antofagasta PLC will offset losses from the drop in Antofagasta PLC's long position.
The idea behind Bristol Myers Squibb and Antofagasta PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets